Your shopping cart is currently empty

plCSA-BP is a placental CSA-binding peptide that specifically binds to trophoblastic cells without interacting with other cell types in the placenta or with CSA-expressing cells in other tissues. It can direct nanoparticles to deliver payloads, such as Indocyanine green (ICG) and Methotrexate (MTX), for targeted placental drug delivery, highlighting its potential in placenta-specific drug delivery research.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | plCSA-BP is a placental CSA-binding peptide that specifically binds to trophoblastic cells without interacting with other cell types in the placenta or with CSA-expressing cells in other tissues. It can direct nanoparticles to deliver payloads, such as Indocyanine green (ICG) and Methotrexate (MTX), for targeted placental drug delivery, highlighting its potential in placenta-specific drug delivery research. |
| In vivo | plCSA-BP (50 ng/mL) is co-localized with trophoblast cells in mouse placenta at E6.5, E8.5, E10.5, and E12.5, but it does not bind to the embryo, junctional zone, or decidua; similar effects are observed in human placenta. It specifically binds to placental CSA expressed in murine labyrinth and human syncytiotrophoblasts. When plCSA-BP (5 mg/kg, intravenously injected at E12.5 or E15.5) is conjugated to nanoparticles, it specifically delivers ICG to trophoblast cells in pregnant mice at stages E12.5 or E15.5. Additionally, plCSA-BP (5 mg/kg, intravenously injected every other day from E6.5 to E14.5) linked to nanoparticles efficiently targets MTX to placental cells, severely impairing placental and fetal development by targeting placental trophoblast cells. |
| Molecular Weight | 3186.61 |
| Formula | C142H221N35O44S2 |
| Cas No. | 2294870-89-4 |
| Smiles | [C@@H](CC1=CN=CN1)(NC([C@H](CC2=CC=CC=C2)NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC(CNC([C@@H](NC([C@@H](NC([C@H](CC3=CC=CC=C3)NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@H](CC4=CC=CC=C4)NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@H](CCC(O)=O)N)=O)CC(O)=O)=O)[C@@H](C)C)=O)CCCCN)=O)CC(O)=O)=O)[C@H](CC)C)=O)CC(N)=O)=O)=O)CC(O)=O)=O)[C@@H](C)O)=O)CCCCN)=O)CCC(O)=O)=O)CCCCN)=O)=O)CC(C)C)=O)C)=O)=O)CS)=O)CC(C)C)=O)[C@H](CC)C)=O)C(C)C)=O)CO)=O)=O)C(N[C@H](C(NCC(N[C@H](C(N[C@H](C(O)=O)CS)=O)CCCCN)=O)=O)CCC(O)=O)=O |
| Sequence | Glu-Asp-Val-Lys-Asp-Ile-Asn-Phe-Asp-Thr-Lys-Glu-Lys-Phe-Leu-Ala-Gly-Cys-Leu-Ile-Val-Ser-Phe-His-Glu-Gly-Lys-Cys |
| Sequence Short | EDVKDINFDTKEKFLAGCLIVSFHEGKC |
| Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.